Actively Recruiting
Mycobacteria Registry Study: Prospective Observational Study in Austria
Led by Ludwig Boltzmann Institute for Lung Health · Updated on 2024-07-26
1000
Participants Needed
3
Research Sites
N/A
Total Duration
On this page
Sponsors
L
Ludwig Boltzmann Institute for Lung Health
Lead Sponsor
S
Sigmund Freud PrivatUniversitat
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to collect detailed data on patients diagnosed with tuberculosis (TB) or non-tuberculous mycobacteria (NTM) infections in Austria. The study is observational and does not involve additional treatments, focusing instead on understanding risk factors for death related to these infections over time. It documents the natural course of therapy as patients receive their regular medical care. Participants in this study are those already undergoing treatment for TB or NTM infections as part of their routine care. The study will gather clinical and epidemiological information throughout the treatment period without altering the therapy being received. No experimental interventions are involved. During participation, individuals will have their health and treatment progress monitored through data collection over a long period, up to 30 years. Researchers will evaluate mortality rates and identify risk factors for death related to mycobacterial infections. This long-term observation helps improve understanding of these diseases and their outcomes without requiring additional procedures or treatments from participants.
CONDITIONS
Brief Title
Mycobacteria Registry Study: Prospective Observational Study in Austria
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection
- Individuals aged 18 years or older
- Written informed consent
You will not qualify if you...
- Unable to understand and properly judge participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 30 years
Participants with Mycobacterium infections are observed over a long period to assess mortality, prevalence, patient cohorts, and risk factors.
Trial Site Locations
Total: 3 locations
1
Klinik Hietzing
Vienna, Austria, 1130
Actively Recruiting
2
Klinik Penzing
Vienna, Austria, 1140
Actively Recruiting
3
Ludwig Boltzmann Institut for Lung Health
Vienna, Austria, 1140
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here